Skip to main content
OpenTrials
Completed

NCT Number: NCT03666260

Analgesia in Total Hip Arthroplasty by Quadratus Lumborum Block

Patients are painful after total hip arthroplasty. These patients have significant co-morbidities. Analgesics cause significant side effects in this population. Locoregional analgesia is therefore an effective means of reducing the consumption of opioids in this surgery.

The "gold standard" of locoregional analgesia after Total Hip Arthroplasty is the femoral block. However, a new technique has recently been described: the Quadratus Lumborum Block.

The comparison of these two techniques is lacking in the literature. The comparison of the Quadratus Lumborum Block to the femoral block in Total Hip arthroplasty is important in the analgesic strategy of patients undergoing this surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–95 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Damien JOLLY

Reims, France

About this study

The aim of this study is to compare the clinical efficacy of two regional locoregional analgesia strategies in total hip replacement surgery: the ultrasound-guided Quadratus Lumborum Block and the ultrasound-guided femoral block.

This is a double-blind, randomized study in prospective inclusion with a superiority test. Two groups of patients will be compared: a group of patients with a quadratus lumborum block and a group of patients with a femoral block.

Management (quadratus lumborum block or femoral block) will be randomized. The randomization will be stratified on the type of anesthesia (spinal anesthesia and general anesthesia). Randomization will be done on the day of surgery to determine the patient's treatment group. The surgical procedure will not be modified by the participation of the patent in the study.

Patients who would benefit from total hip replacement surgery in the Reims University Hospital and who agreed to participate in the study were included.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients eligible for total hip replacement surgery in Reims University Hospital
  • Patients agreeing to participate in the research and having signed informed consent
  • between 18 yo and 95 yo
  • Patients affiliated to a social security system

Exclusion criteria

  • Patients with allergy to local anesthetics
  • Patients with neuropathy
  • Patients with an ASA score of 4
  • Patients undergoing revision surgery for total hip arthroplasty
  • Patients receiving anterior hip total hip replacement surgery
  • Patients with a contraindication to the realization of the quadratus lumborum block, femoral block or spinal anesthesia (clinical coagulopathy, infection at the point of puncture ...)
  • Patients refusing the proposed techniques

Treatment and study plan

quadratus lumborum block

Procedure

Quadratus Lumborum Block with echography

femoral block

Procedure

femoral block with echography

Primary outcomes

  1. morphine consumption

    Time frame: 24 hours

    Morphine consumption during the 24 hours postoperative

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Registry information

Official study title

Comparison of the Clinical Effectiveness of the Quadratus Lumborum Block and Femoral Block in the Analgesia of Total Posterior Hip Arthroplasty

Acronym: ATHAQLuB

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Sep 11, 2018
Registry last updated
May 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.